Company: CERO
Filing Date: 2025-11-20
Form Type: 424B3
Source: 0001213900-25-113118
Chunk: 51

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-11-20
Form: 424B3
Chunk 51
---
 and Holder acknowledges was mutually
beneficial. Pursuant to the Waiver Agreement, the Series D Preferred Holders waived Section 8(a) of the Series D COD, in part, solely
with respect to the Existing Series C Conversions, such that the Prior Series C Conversion Shares shall be deemed “Excluded Securities”
under Section 8(a) (the “Antidilution Waiver”).

Bankruptcy Triggering Event Redemption Right. Upon any bankruptcy Series D Triggering Event, the Company shall immediately redeem in cash all amounts
due under the Series D Preferred Stock at a 25% premium to the greater of (x) the amount of shares of Series D Preferred
Stock then outstanding and (y) the equity value of the shares of Series D Preferred Stock then outstanding, unless the holder
waives such right to receive such payment. The equity value of the Common Stock underlying the Series D Preferred Stock is calculated
using the greatest closing sale price of the Common Stock on any trading day immediately preceding such bankruptcy Series D
Triggering Event and the date the Company makes the entire payment required.

Change of Control Exchange.
Upon a change of control of the Company, each holder may require the Company to exchange the holder’s shares of Series D Preferred
Stock for consideration equal to the Change of Control Election Price (as defined in the Series D Certificate of Designations), to
be satisfied at the Company’s election in either (x) cash or (y) rights convertible into such securities or other assets
to which such holder would have been entitled with respect to such shares of Common Stock had such shares of Common Stock been held by
such holder upon consummation of such corporate event.

Company Optional Redemption.
At any time the Company shall have the right to redeem in cash all, but not less than all, the shares of Series D Preferred Stock
then outstanding at a 25% redemption premium to the greater of (x) the amount of shares being redeemed, and (y) the equity value
of the Common Stock underlying the Series D Preferred Stock. The equity value of the Common Stock underlying the Series D Preferred
Stock is calculated using the greatest closing sale price of the Common Stock on any trading day immediately preceding the date the
Company notifies the holders of the Company’s election to redeem and the date the Company makes the entire payment required.

Fundamental Transactions.
The Certificate of Designations prohibit the Company from entering specified fundamental transactions (including, without limitation,
mergers, business combinations and similar transactions) unless the Company (